All the latest movements and new board appointments in VC-backed or PE-backed companies
– USA, MA – Dyax Corp. (NASDAQ: DYAX), a biopharmaceutical company focused on the development and commercialization of novel biotherapeutics for unmet medical needs, today announced the appointment of Abbie Celniker, Ph.D.,…
– UK, London – Zesty Limited, a leading platform in the UK for consumer healthcare, today announced the successful completion of its $7.2 million Series A financing, one of the largest early stage Digital Health financings in Europe to date.…
– USA, NC – Precision BioSciences, the genome editing company, today announced the closing of a $25.6 million Series A financing led by venBio.…
– USA, NC – Spyryx Biosciences, Inc., a privately-held biopharmaceutical company developing novel therapeutics for respiratory diseases, including cystic fibrosis (CF) and chronic obstructive pulmonary disorder (COPD), announced today that it has secured $18 million in Series A venture capital financing from Canaan Partners, Hatteras Venture Partners and 5AM Ventures.…
– USA, CA – Moximed®, Inc., developer of the KineSpring® System, a joint unloading knee implant for pre-arthroplasty patients who hope to lead an active lifestyle, announced a round of financing of approximately $33MM that includes new investor Vertex Venture Holdings Ltd.…
